Such as, in triple destructive breast cancer (TNBC),25 and in hepatocellular carcinoma,26 DNA methylation profiles have assisted into the identification of distinct subgroups with clinical relevance. Epigenetic techniques have also helped to the development of prognostic assessments to evaluate the sensitivity of cancer cells to distinct prescription drugs.27 was https://directivepublications.org/world-journal-of-clinical-cancer-research/